Fragile X syndrome is recognized as the most common inherited cause of mental retardation in western countries. The prevalence of the fragile X syndrome in Asian populations is uncertain. We report a multi-institutional collaborative study of molecular screening for the fragile X syndrome from 1,127 Chinese mentally retarded (MR) individuals. We found that 2.8% of the Chinese MR population screened by DNA analysis had the fragile X full mutation. Our screening indicated that the fragile X syndrome prevalence was very close to that of Caucasian subjects. In addition, we found that 62.5% of fragile X chromosomes had a single haplotype for DXS548-FRAXAC1 (21-18 repeats) which was present in only 9.7% of controls. This unique distribution of microsatellite markers flanking the FMR1 CGG repeats suggests that the fragile X syndrome in Chinese populations, as in the Caucasian, may also be derived from founder chromosomes.

This work is to fabricate thermo responsive nanofibers of which the thermo response temperatures could be easily tuned, and of which the fibrous shapes could be maintained after heating-cooling cycles in aqueous solution. The nanofibers were further fabricated into a nonwoven mat with size-variable pores for temperature controlled release of a model drug, Erlotinib. The thermo responsive nanofibers were electrospun from the copolymers of PMMA-co-PVCL (synthesized from MMA and PVCL, and had different LCSTs) by changing the solvents and the ratio of initiator/monomer. FT-IR and 1 H NMR were used for molecular structural characterization; UV-vis spectra were used for LCST measurement; SEM and metalloscope were used to determine the optimal electrospinning parameters and to observe the shape maintaining abilities of the nanofibers after the heating-cooling recycles. Then, anti-cancer drug, Erlotinib, was incorporated into PMMA/PVCL nanofibers (represent as 'model I'), or put in a drug reservoir and covered with the PMMA/PVCL electrospinning mat (presented as 'model II'). UV-vis spectra were used to study the drug release behavior of each model. Results indicate that in model I, drug release was "switch on" below LCST, and "switch off" above LCST; in model II, drug release was faster above LCST than below LCST.

Nanoscale molecularly imprinted polymers (MIPs) could offer high binding capacity and fast mass transfer, but their removal after adsorption is costly and time-consuming. In this paper, Fe3O4@SiO2 nanoparticles were synthesized...

IntroductionThe B.1.617.2 (Delta) variant of SARS-COV-2 has caused a surge in COVID-19 cases worldwide, placing a great burden on the health care system under the zero-tolerance epidemic prevention policy in China. The present study aimed to investigate the prevalence of anxiety among health care workers during the spread of the SARS-CoV-2 Delta variant, and to discuss the mediating role of positive coping style between resilience and anxiety, and the moderating role of general self-efficacy.MethodConnor-Davidson Resilience scale (CD-RISC), Generalized Anxiety Disorder Scale (GAD-7), General Self-efficacy Scale (GSES) and Simplified Coping Style Questionnaire (SCSQ) were used in this cross-sectional study among 390 healthcare workers in Jiangsu Province, China. Mackinnon's four-step procedure was applied to test the mediation effect, and Hayes PROCESS macro was conducted to examine the moderated mediation model.ResultsThe prevalence of anxiety among Chinese healthcare workers during the spread of the SARS-CoV-2 Delta variant was 41.8%. Male, unmarried, childless and younger subjects reported higher levels of anxiety. Positive coping partially mediated the effect of resilience on anxiety among healthcare workers and the indirect effect was stronger with the increase of general self-efficacy.ConclusionsAnxiety was prevalent among healthcare workers during the spread of SARS-CoV-2 Delta variant. This research sheds new light on the potential mechanism underlying the association between resilience and anxiety and provides new insight into the prevention of anxiety among healthcare workers during the spread of the SARS-CoV-2 Delta variant.